
Hepatitis B Vaccine Administration | Hepatitis B | CDC
Jan 31, 2025 · The United States Food and Drug Administration (FDA) has licensed three single-antigen vaccines (Engerix-B, Heplisav-B, and Recombivax HB), and three combination vaccines (Pediarix, Vaxelis, and Twinrix) to protect against hepatitis B.
Official Site for RECOMBIVAX HB® [Hepatitis B Vaccine (Recombinant)]
RECOMBIVAX HB is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approved for use in individuals of all ages. RECOMBIVAX HB Dialysis Formulation is approved for use in adult predialysis and …
Hepatitis B Vaccine (Recombinant) - FDA
List of Hepatitis B Vaccine (Recombinant)products. The .gov means it’s official. Federal government websites often end in .gov or .mil.
RECOMBIVAX HB® [Hepatitis B Vaccine, Recombinant] is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approved for use in...
Recombivax HB | FDA - U.S. Food and Drug Administration
Apr 24, 2019 · RECOMBIVAX HB is indicated for vaccination against infection caused by all known subtypes of hepatitis B virus.
Hepatitis b vaccine (intramuscular route) - Mayo Clinic
Hepatitis B vaccine recombinant is used to prevent infection by the hepatitis B virus. The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Hepatitis B vaccine recombinant is made without any human blood or blood products or any other substances of human origin.
Hepatitis B Vaccine (Recombinant) Information - Drugs.com
Jan 11, 2024 · Easy-to-read patient leaflet for Hepatitis B Vaccine (Recombinant). Includes indications, proper use, special instructions, precautions, and possible side effects. Skip to main content
Recombinant hepatitis B vaccine (Engerix-B): a review of its ... - PubMed
Engerix-B (Hep-B [Eng]) is a noninfectious recombinant DNA vaccine containing hepatitis B surface antigen (HBsAg). It is produced from genetically engineered yeast (Saccharomyces cerevisiae).
Hepatitis B Vaccine Recombinant (Monograph) - Drugs.com
Hepatitis B vaccine contains hepatitis B surface antigen (HBsAg) and is used to stimulate active immunity to hepatitis B virus (HBV) infection. Commercially available in the US as monovalent vaccines (HepB; Engerix-B, Recombivax HB).
Hepatitis B Vaccine (Recombinant) - DrugBank Online
Hepatitis B Vaccine is an ingredient in the EMA-withdrawn product Quintanrix. It is marketed in Canada as Engerix B. It is also a part of Twinrix (Hep A/Hep B vaccine) available also in Canada. The hepatitis B virus induces a severe form of viral hepatitis. Other causative agents are hepatitis A virus, and the non-A, non-B hepatitis viruses.
- Some results have been removed